Avicena Sentinel

Fast, Accurate, Affordable, and Scalable Pathogen Screening

The most scalable rapid molecular diagnostics platform in the world, offering a unique surge capability of up to 100,000 tests daily.

Next-Generation Molecular Diagnostics

The Avicena Sentinel is the world’s most scalable rapid molecular diagnostics platform.

Available in two versions, the Sentinel ULTRA and Sentinel Mini cater to diverse testing needs, making it economically viable for both low and high-volume scenarios.

With accuracy comparable to PCR, the Avicena Sentinel outperforms in speed and affordability, while preserving the capability to screen for multiple pathogens simultaneously.

Effortless Saliva Sample Collection

Quick Saliva Sample Collection

Simply swab your mouth with our microswab to gather the optimal saliva volume. 


Secure in Barcoded Sample Tube

Secure the swab in the provided barcode-labeled sample tube that contains a stabilising buffer solution.


The Sentinel Platform

Sentinel Mini

Surge capacity up to 384 hourly
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting

Sentinel ULTRA V3

Surge capacity up to 100,000 daily
Up to 10x faster than PCR
Continuous Flow Processing
Fully Automated

Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting

The Future of Biosecurity

The flexible Sentinel system can rapidly adapt to test for current and emerging pathogen threats.

Human Biosecurity

Emerging Threats

Lumpy Skin Disease
Japanese Encephalitis Virus
Zika Virus
Bioengineered Pathogens


Blood Banks

Hepatitis B
Hepatitis C

Antibiotic Resistant Pathogens

Drug-Resistant Tuberculosis


Human & Zoonotic influenza
Emerging Pandemic Flu Threats

Animal Biosecurity


Lumpy Skin Disease
Foot & Mouth Disease






African Swine Fever
Swine Flu



Avian Flu


Enforce your First Line of Defence

Rapid detection, reporting and response to disease outbreaks is the first line of defence.

Contact our team to learn what an effective and rapid implementation looks like.


Scientific Publications

TGA Authorised1

Sentinel has achieved a Class 1 IVD listing on the Australian Register of Therapeutic Goods (ARTG) under the TGA.

CE-Marked Chemistry

CE-Mark for COVID test chemistry developed by Hayat Genetics, acquired by Avicena Systems.



Avicena holds several patent pending innovations that enable our groundbreaking performance.

Intended Use

The Avicena Sentinel instrument is intended for trained laboratory professionals to run isothermal amplification assays. Diagnostic use of the Sentinel requires IVD reagents and laboratory workflows which have been authorised by relevant regulatory agencies in each jurisdiction and by Avicena Systems as compatible with the instrument.